JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Scope & Guideline
Connecting research and practice in the fight against cancer.
Introduction
Aims and Scopes
- Pharmaceutical Care in Oncology:
The journal emphasizes the role of pharmacists in providing comprehensive medication management, ensuring safe and effective use of anticancer therapies, and enhancing patient education. - Adverse Drug Reactions and Toxicity Management:
Research on the identification, prevention, and management of adverse drug reactions related to cancer therapies, focusing on improving patient safety and quality of life. - Clinical Pharmacy Interventions:
The journal highlights studies on clinical pharmacy interventions, including medication reconciliation, therapeutic drug monitoring, and the integration of clinical pharmacists in oncology teams. - Pharmacotherapy Research:
The focus includes pharmacotherapy outcomes, including efficacy and safety of various cancer treatments, comparative effectiveness studies, and advancements in drug regimens. - Patient-Centered Care:
Research related to patient experience, adherence to medication, and the impact of educational interventions on cancer patients' knowledge and management of their therapies. - Innovative Pharmacy Practices:
Exploration of new methodologies in pharmacy practice, including the use of technology, telepharmacy, and automation in medication management for oncology patients.
Trending and Emerging
- Immunotherapy and Targeted Therapies:
There is a growing emphasis on research related to immunotherapy and targeted therapies, reflecting their increasing use and complexity in cancer treatment. - Pharmacogenomics and Personalized Medicine:
Research into pharmacogenomics is on the rise, focusing on how genetic variations affect patient responses to cancer medications, promoting personalized treatment strategies. - Telepharmacy and Remote Care:
The incorporation of telepharmacy in oncology has gained traction, particularly in light of the COVID-19 pandemic, facilitating remote patient monitoring and medication management. - Patient Education and Engagement:
An increased focus on the importance of patient education and engagement strategies that enhance adherence and understanding of treatment protocols is evident. - Management of Adverse Effects:
Emerging research is increasingly centered on strategies to manage and mitigate adverse effects associated with modern cancer therapies, including immune-related adverse events. - Cost-Effectiveness Studies:
There is an upward trend in studies assessing the economic impact of cancer therapies, emphasizing the need for cost-effective treatment options in oncology.
Declining or Waning
- Traditional Chemotherapy Protocols:
Research focused specifically on traditional chemotherapy regimens appears to be declining as newer targeted therapies and immunotherapies gain prominence. - Single-Agent Studies:
There is a noticeable decrease in publications centered on single-agent chemotherapy studies, as multi-agent and combination therapies become the focus of clinical research. - Pharmacy Practice Guidelines:
While guidelines remain important, there is a shift away from generic pharmacy practice guidelines towards more specific, evidence-based protocols tailored to individual patient needs. - Focus on Pharmacokinetics Alone:
Research that solely emphasizes pharmacokinetic studies without considering pharmacodynamics and clinical outcomes has seen less attention as a more holistic approach gains traction. - Limited Scope on Complementary Therapies:
Interest in complementary and alternative medicine approaches in oncology has waned, with a stronger emphasis on evidence-based pharmacotherapy.
Similar Journals
JOURNAL OF PHARMACY PRACTICE AND RESEARCH
Championing advancements in pharmacy and pharmacology.JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.
SAUDI PHARMACEUTICAL JOURNAL
Shaping the future of pharmacology with cutting-edge insights.SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.
International Journal of Clinical Pharmacy
Elevating Clinical Practices with Groundbreaking FindingsThe International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.
FARMACIA HOSPITALARIA
Enhancing healthcare discourse with accessible pharmaceutical research.FARMACIA HOSPITALARIA, published by Elsevier Science Inc, is a premier open access journal that has been contributing to the fields of Medicine and Pharmacology since its inception in 1990. Based in the Netherlands, this journal provides a vital platform for the dissemination of high-quality research related to hospital pharmacy practice, medication management, and therapeutic outcomes. With an impressive scope that bridges clinical and pharmaceutical sciences, it positions itself within the 3rd quartile of both Medicine (miscellaneous) and Pharmacology categories, showcasing its relevance and evolving contributions to healthcare discourse. Since adopting an open access model in 2005, FARMACIA HOSPITALARIA has committed to making its research widely available, facilitating knowledge sharing among professionals and academics alike. Researchers and practitioners looking to stay updated with the latest advancements in pharmacy and clinical practices will find this journal an indispensable resource.
Journal of Pharmacy and Bioallied Sciences
Bridging Theory and Practice in BioengineeringThe Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.
Pharmacy
Exploring the frontiers of pharmaceutical sciences without barriers.Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.
Exploratory Research in Clinical and Social Pharmacy
Exploring the intersection of clinical and social pharmacy.Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.
DRUGS & THERAPY PERSPECTIVES
Fostering Excellence in Drug Research and Clinical ApplicationsDRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.
Journal of Research in Pharmacy Practice
Unlocking the future of pharmacy with impactful studies.Journal of Research in Pharmacy Practice, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a premier open-access journal dedicated to advancing the field of pharmaceutical sciences through rigorous research and innovative practices. Since its inception, the journal has aimed to bridge gaps between pharmacy practice and research, providing a platform for researchers, professionals, and students alike to disseminate their findings and insights. With a commitment to high-quality, peer-reviewed content, the journal covers a wide array of topics including clinical pharmacy, medication management, and healthcare policies, contributing to the enhancement of global healthcare practices. The journal is easily accessible online, having embraced an open-access model since 2012, ensuring that valuable research is freely available to all. Engaging with the Journal of Research in Pharmacy Practice not only facilitates knowledge exchange but also aids in the continuous evolution of pharmacy practice, emphasizing its critical role in healthcare delivery and patient outcomes.
Pharmacy Practice-Granada
Fostering collaboration to elevate pharmacy education and practice.Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.